ENGLEWOOD, Colo., May 3, 2022
/PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical
technology company specializing in the manufacture and sale of
non-invasive medical devices for pain management, rehabilitation,
and patient monitoring, ranked 250 out of 500 on The Financial
Times list of Americas' Fastest Growing Companies in 2022.
"Zynex's unrelenting growth has been acknowledged, and we are
honored to be included among such an innovative group of
companies," said Thomas Sandgaard,
Zynex CEO. "Zynex has seen a compound annual growth rate (CAGR) of
50.7% percent between 2017 and 2020 and an overall growth rate of
242% in that same period. Additionally, we are one of only twelve
publicly traded healthcare focused companies to be recognized. We
are pleased by this recognition and look forward to our continued
expansion in the years to come."
The list, published by The Financial Times, is compiled
together with Statista, a leading provider of market data, to
recognize the resilience of companies in response to COVID-19 and
acknowledge their ability to innovate. This is the third annual
publication of the list.
About Zynex, Inc.
Zynex, founded in 1996, develops, manufactures, markets, and
sells medical devices used for pain management and rehabilitation
as well as non-invasive fluid, sepsis and laser-based pulse
oximetry monitoring systems for use in hospitals. For additional
information, please visit: www.zynex.com
Investor Contact
Gilmartin Group
650 Fifth Ave., Suite 2720
New York, NY 10019
IR@zynex.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/zynex-ranks-250-in-financial-times-list-of-the-americas-fastest-growing-companies-2022-301538186.html
SOURCE Zynex